Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport
- 4 March 2003
- journal article
- Published by Elsevier in Brain Research Bulletin
- Vol. 60 (3) , 297-306
- https://doi.org/10.1016/s0361-9230(03)00043-1
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Evidence that Cereport's Ability to Increase Permeability of Rat Gliomas Is Dependent Upon Extent of Tumor Growth: Implications for Treating Newly Emerging Tumor ColoniesExperimental Neurology, 2000
- 902: Survival following treatment with RMP-7 and carboplatin in malignant glioma who grade III–IV: Comparison with matched controlsEuropean Journal Of Cancer, 1997
- Treatment of brain metastases from small cell lung cancer. Is there a difference with other metastatic sites?Lung Cancer, 1997
- RMP-7CNS Drugs, 1997
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Cloning and pharmacological characterization of a human bradykinin (BK-2) receptorBiochemical and Biophysical Research Communications, 1992
- Bradykinin Receptors of Cerebral Microvessels Stimulate Phosphoinositide TurnoverJournal of Cerebral Blood Flow & Metabolism, 1991
- Structure-activity studies of bradykinin and related peptides. B2-receptor antagonists.Hypertension, 1991
- Bradykinin receptors undergo ligand-induced desensitizationBiochemistry, 1990
- Some Old and Some New Ideas on Kinin MetabolismJournal of Cardiovascular Pharmacology, 1990